Topical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eye. 2014

Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, 6565 Fannin Street, NC505, Houston, TX 77030, USA; Shenyang He Eye Hospital, Shenyang, Liaoning, China.

Evidence suggests that the cytokine interferon (IFN)-γ released by natural killer and CD4(+) T cells contributes to the conjunctival goblet cell (GC) loss in dry eye. The purpose of this study was to investigate if topical neutralization of IFN-γ prevents or alleviates GC loss in an experimental desiccating stress (DS) model of dry eye. In this study, we found that topical IFN-γ neutralization significantly decreased DS-induced conjunctival GC loss. This was accompanied by decreased epithelial apoptosis, and increased IL-13 and decreased FoxA2 expression in the forniceal conjunctiva. To establish that IFN-γ produced by pathogenic CD4(+) T cells contributes to DS-induced GC loss, adoptive transfer of CD4(+) T cells isolated from DS exposed donors to naïve RAG-1(-/-) recipient mice was performed. Similar to the donor mice, topical IFN-γ neutralization decreased conjunctival GC loss, suppressed apoptosis and increased IL-13 expression in adoptive transfer recipients. In summary, this study demonstrated that topical neutralization of IFN-γ prevents GC loss via modulating apoptosis and maintaining IL-13 signaling.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D003228 Conjunctiva The mucous membrane that covers the posterior surface of the eyelids and the anterior pericorneal surface of the eyeball. Bulbar Conjunctiva,Palpebral Conjunctiva,Plica Semilunaris of Conjunctiva,Plicae Semilunares of Conjunctiva,Tunica Conjunctiva,Conjunctiva, Bulbar,Conjunctiva, Palpebral,Conjunctivas
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
April 1975, Investigative ophthalmology,
Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
January 2019, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics,
Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
November 2018, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
November 2020, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics,
Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
March 2024, Clinical & experimental ophthalmology,
Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
June 2007, Investigative ophthalmology & visual science,
Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
November 2015, Investigative ophthalmology & visual science,
Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
August 2020, Scientific reports,
Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
December 2023, Translational vision science & technology,
Xiaobo Zhang, and Cintia S De Paiva, and Zhitao Su, and Eugene A Volpe, and De-Quan Li, and Stephen C Pflugfelder
March 1988, Bulletin of the International Union against Tuberculosis and Lung Disease,
Copied contents to your clipboard!